- Dr. Roscoe M. Moore, Jr. to join Board -
PRINCETON, N.J. and SAN DIEGO, June 4 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the addition of Roscoe Moore Jr., D.V.M., Ph.D., D.Sc. to their Scientific Advisory Board.
"We expect Dr. Moore to contribute significantly to our already robust Scientific Advisory Board. His expertise across all areas of public health and infectious diseases will be a tremendous asset to Tobira Therapeutics," said James Sapirstein, CEO.
Dr. Moore, President, PH RockWood Corporation, Rockville, Maryland and Pretoria, South Africa, is the Former Assistant United States Surgeon General and Rear Admiral, United States Public Health Service (Retired). Until his retirement Dr. Moore, Jr. served with the United States Department of Health and Human Services (HHS) and was for the last twelve years of his career the principal person responsible for development support within the Office of the Secretary, Health and Human Services (HHS). Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control (CDC) and Prevention. He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. He served as the Chief Epidemiologist with the Center for Devices and Radiological Health, FDA. He directed the Epidemiology and Biostatistics Program and was an Assistant Professor of Oncology within the
Dr. Moore received his undergraduate and Doctor of Veterinary Medicine degrees from
Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service (USPHS) entering with the U.S. National Institutes of Health and rising to the rank of Assistant United States Surgeon General (Rear Admiral, USPHS) within the Immediate Office of the Secretary, HHS. He was selected as Chief Veterinary Medical Officer, USPHS, by Surgeon General C. Everett Koop.
About Tobira Therapeutics Inc.
Tobira Therapeutics is a private biopharmaceutical company which is focused on developing and commercializing innovative antiviral compounds to treat HIV disease. The company was founded in 2006 by Eckard Weber, MD, a partner at the venture capital firm Domain Associates, to develop novel treatments for HIV disease. Tobira has assembled a highly experienced management team with decades of clinical and commercial development experience specifically in HIV/AIDS drug development.
Contact: Tobira Therapeutics Inc. Antoinette Bobbitt firstname.lastname@example.org Tel: 609-897-1102 www.tobiratherapeutics.com
|SOURCE Tobira Therapeutics Inc.|
Copyright©2009 PR Newswire.
All rights reserved